Dr. Aronova is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
480 Bedford Road
Mount Kisco, NY 10549Phone+1 914-861-3566Fax+1 212-849-2441
Summary
- I am a board-certified general surgeon trained at Cornell in NYC who completed an endocrine surgery fellowship at Mt Sinai in NYC in July 2018.
Education & Training
- Icahn School of Medicine at Mount SinaiFellowship, Endocrine Surgery, 2017 - 2018
- New York Presbyterian Hospital (Cornell Campus)Residency, Surgery, 2010 - 2017
- Weill Cornell Graduate School of ScienceMSc, Clinical and Translational Investigation, 2013 - 2015
- Weill Cornell Graduate School of Medical SciencesMaster's, Clinical and Translational Investigation, 2013 - 2015
- Weill Cornell MedicineClass of 2010
- Cornell UniversityBS, Human biology, health and society, 2002 - 2006
- Cornell UniversityB.S., Human Biology Health and Society, 2002 - 2006
Certifications & Licensure
- NY State Medical License 2010 - 2026
- CT State Medical License 2019 - 2024
- American Board of Surgery Surgery
Awards, Honors, & Recognition
- Honors in Research 2010
Publications & Presentations
PubMed
- 16 citationsUCHL1 loss alters the cell-cycle in metastatic pancreatic neuroendocrine tumors.Brendan M. Finnerty, Maureen D. Moore, Akanksha Verma, Anna Aronova, Shixia Huang
Endocrine-Related Cancer. 2019-04-01 - 3 citationsCHL1 expression differentiates Hürthle cell carcinoma from benign Hürthle cell nodules.Wei Li, Shujun Xia, Anna Aronova, Irene M. Min, Akanksha Verma
Journal of Surgical Oncology. 2018-11-01 - 22 citationsProtein Expression of PTTG1 as a Diagnostic Biomarker in Adrenocortical Carcinoma.Minerva A. Romero Arenas, Timothy G. Whitsett, Anna Aronova, Samuel A. Henderson, Janine LoBello
Annals of Surgical Oncology. 2018-03-01
Journal Articles
- Protein Expression of PTTG1 as a Diagnostic Biomarker in Adrenocortical CarcinomaRomero Arenas MA, Whitsett TG, Aronova A, Henderson SA, LoBello J, Habra MA, Grubbs EG, Lee JE, Sircar K, Zarnegar R, Scognamiglio T, Fahey TJ, Perrier ND, Demeure MJ, Ann Surg Oncol, 1/1/2018
- STMN1 is overexpressed in adrenocortical carcinoma and promotes a more aggressive phenotype in vitroAronova A, Min IM, Crowley MJ, Panjwani SJ, Finnerty BM, Scognamiglio T, Liu YF, Whitsett TG, Garg S, Demeure MJ, Elemento O, Zarnegar R, Fahey TJ III, Ann Surg Oncol, 1/1/2018
- Well-Differentiated Thyroid Cancer Neovasculature Expresses Prostate-Specific Membrane Antigen-a Possible Novel Therapeutic TargetMoore M, Panjwani S, Mathew R, Crowley M, Liu YF, Aronova A, Finnerty B, Zarnegar R, Fahey TJ 3rd, Scognamiglio, T, Endocr Pathol, 1/1/2017
- Join now to see all
Abstracts/Posters
- Silencing STMN1 expression decreases aggressive phenotype in adrenocortical carcinoma.Aronova A, Min IM, Crowley MJ, Finnerty BF, Scognamiglio T, Liu YF, Whitsett TG, Shag S, Demeure MJ, Elemento O, Zarnegar R, Fahey III TJ, American Association of Endocrine Surgeons Meeting, Orlando, FL, 1/1/2017
- Basic Science in Surgical Research: An Endangered Species?Aronova A, Moore M, Antonacci C, Goldfield V, Finnerty BM, Zarnegar R, Fahey TJ III, American College of Surgeons Meeting, Chicago, IL, 1/1/2015
- Cost Disparity between Healthcare Systems - It's Not the Surgeons: A Cost Analysis of Thyroid Cancer Care Between the U.S. and France.Finnerty B, Brunaud L, Mirallie E, McIntyre C, Aronova A, Fahey TJ III, Zarnegar R, American Association of Endocrine Surgeons Meeting, Nashville, TN, 1/1/2015
- Join now to see all
Other Languages
- Russian
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: